| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ccee8e1d48352b3e8c8af081eb34375 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2006-80 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09C1-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N57-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N57-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09C3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C04B16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09C1-021 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D21H19-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K23-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D21H19-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N57-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09C1-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K23-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D21H21-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C04B14-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09C3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D21H19-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09C1-02 |
| filingDate |
2004-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6692e2f494d6a0dee4942b15decc756d |
| publicationDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2324711-T3 |
| titleOfInvention |
TREATMENT OF SUSPENSIONS. |
| abstract |
The use of a composition comprising: (a) a tetrakis (hydroxyorganic) phosphonium salt (herein, THP + salt) selected from tetrakis (hydroxymethyl) phosphonium sulfate, tetrakis (hydroxymethyl) phosphonium chloride, phosphate tetrakis (hydroxymethyl) phosphonium, tetrakis (hydroxymethyl) phosphonium nitrate and tetrakis (hydroxymethyl) phosphonium oxalate; and (b) a dispersion agent selected from the group consisting of: (i) phosphonated compounds containing at least one tertiary nitrogen atom; and (ii) homopolymers of unsaturated acids; for the treatment of an inorganic suspension to keep the suspension in a substantially homogeneous phase and to preserve the suspension against bacterial contamination. |
| priorityDate |
2003-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |